Decibel, Regeneron get UK regulator nod to start trial of hearing loss gene therapy

DNA molecule

Artur Plawgo

Decibel Therapeutics (NASDAQ:DBTX) said its clinical trial application (CTA) received approval from the U.K.’s Medicines and Healthcare products Regulatory Agency (MHRA) for starting a phase 1/2 trial in children of gene therapy DB-OTO.

DB-OTO, which is being developed in

Source link

5 Trading strategies to make money

Looking to boost your trading profits?

Get you copy of our FREE Ebook Now !!!